Subscribe
Logo smallSearch

AOTMiT: The Transparency Council will evaluate drugs, benefits and health programs

MedExpress Team

medexpress.pl

Published Feb. 2, 2024 12:11

AOTMiT: The Transparency Council will evaluate drugs, benefits and health programs - Header image
Źródło: AOTMiT
February 5 next meeting of the Transparency Council.

During the session, preparation was planned:

  1. Positions on the qualification of the service "Repositioning and immobilization of a dislocated tooth or group of teeth and removal of a dental splint when replacing or completing treatment" as a guaranteed benefit.
  2. Positions on the evaluation of the drug Keytruda (pembrolizumabum) under the drug program "Treatment of patients with cervical cancer (ICD-10: C53)".

    Content locked

    To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

    If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.

Najciekawsze oferty pracy (przewiń)